Business Context and Reporting Period
Company: Conduent Incorporated (CNDT)
Filing Type: Form 8-K (Current Report)
Date of Report: September 18, 2023
Event: Entry into a Material Definitive Agreement to sell the BenefitWallet health savings account (HSA) and medical savings account (MSA) portfolio to HealthEquity, Inc.
Key Financial Metrics
Transaction Value: Aggregate purchase price of $425 million, subject to adjustment based on actual assets transferred.
Payment Structure: Pro-rata payments based on the relative value of assets transferred in multiple tranches.
Closing Timeline: Expected to close in multiple tranches during the first half of 2024.
Other Metrics: The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period.
Material Changes and Transaction Details
- Asset Transfer: Conduent Business Services, LLC (CBS) will transfer the exclusive right to act as custodian of the HSA and MSA Accounts to HealthEquity.
- Non-Competition: CBS has agreed to a customary non-competition provision preventing participation in certain competitive activities.
- Conditions Precedent: Closing is subject to regulatory approvals (including HSR Act waiting period), absence of governmental prohibitions, execution of master services agreements, and no material customer terminations (specifically those representing >5% of the portfolio).
Guidance, Outlook, and Risks
Outlook: Management anticipates the transaction will be consummated in the first half of 2024, though this is subject to conditions.
Risks and Contingencies:
- Failure to obtain required regulatory approvals or satisfy closing conditions.
- Unexpected costs, liabilities, or delays associated with the transaction.
- Potential negative effects on stock price or operating results due to the transaction announcement or pendency.
- Risk of litigation or regulatory actions.
- Inability to retain key personnel.
Investor Verification Checklist
- Verify the final purchase price adjustment based on actual HSA and MSA assets transferred at closing.
- Monitor the status of regulatory approvals, specifically the Hart-Scott-Rodino Antitrust Improvements Act waiting period.
- Confirm that no Enterprise Partner or Health Plan Partner representing more than 5% of the portfolio has terminated its relationship prior to the Initial Conversion Date.
- Review the execution of the required master services agreement and partner agreement between CBS and HealthEquity.
- Assess the impact of the non-competition provision on Conduent's future strategic options in the benefits administration space.